{
  "trial_id": "NCT03763175",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "age",
      "label": "met",
      "evidence": "text"
    },
    {
      "criterion": "willingness to participate",
      "label": "met",
      "evidence": "text"
    },
    {
      "criterion": "understanding and signing informed consent",
      "label": "met",
      "evidence": "text"
    },
    {
      "criterion": "IBS-C symptoms for at least 6 months prior to diagnosis",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "average score of \u2265 3.0 for daily abdominal pain at its worst (11-point numerical rating scale [NRS]) during and up to the 17 days immediately before randomization",
      "label": "met",
      "evidence": "text"
    },
    {
      "criterion": "average of \u2264 3 CSBMs per week or \u2264 5 SBMs per week during the 17 days immediately before randomization",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "breath methane level \u2265 10 ppm on a lactulose breath test administered at Screening",
      "label": "met",
      "evidence": "text"
    },
    {
      "criterion": "stable, continuous regimen of fiber or probiotics one month before the Screening Visit",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "agreement to refrain from starting a new diet, changing stable dose of supplemental fiber, or changing exercise pattern that may affect IBS-C symptoms from the time of Screening through the end of the study",
      "label": "met",
      "evidence": "text"
    },
    {
      "criterion": "agreement to use an acceptable method of contraception from the time of signing the ICF to 30 days after the final dose of study drug if the patient is a sexually active female of child-bearing potential",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "ability to understand and be willing to sign the written informed consent form",
      "label": "met",
      "evidence": "text"
    },
    {
      "criterion": "willingness and ability to comply with the protocol, including follow-up visits and examinations",
      "label": "met",
      "evidence": "text"
    }
  ],
  "exclusion": [
    {
      "criterion": "loose (mushy) or watery stools for > 25% of their bowel movements (BMs) during the 12 weeks before Screening or during the Screening and Pre-treatment Periods",
      "label": "not_met",
      "evidence": "text"
    },
    {
      "criterion": "history of cathartic colon, laxative, or enema abuse",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She has had IBS-C symptoms for at least 6 months prior to diagnosis and has an average score of \u2265 3.0 for daily abdominal pain at its worst (11-point numerical rating scale [NRS]) during and up to the 17 days immediately before randomization.",
  "_meta": {
    "topic_id": "43",
    "trial_id": "NCT03763175",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}